Alnylam Pharmaceuticals | ALNY - Stock

Stock Price
327.95
Daily Change
-3.29 -0.99%
Monthly
-22.38%
Yearly
18.74%
Q1 Forecast
327.65

Alnylam Pharmaceuticals reported $75.38M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Acadia Pharmaceuticals USD 29.1M 2.97M Sep/2025
Agios Pharmaceuticals USD 32.03M 1.19M Sep/2025
Alnylam Pharmaceuticals USD 75.38M 3.7M Sep/2025
Amgen USD 6.22B 121M Dec/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
BioMarin Pharmaceutical USD 1.38B 42M Sep/2025
Incyte USD 83.45M 24K Sep/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
Moderna USD 332M 92M Sep/2025
Neurocrine Biosciences USD 69.3M 12.4M Sep/2025
Novartis USD 6.42B 114M Sep/2025
PTC Therapeutics USD 52.69M 18.63M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Sarepta Therapeutics USD 1.08B 83.13M Sep/2025
Takeda JPY 1.41T 107.71B Dec/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
Vertex Pharmaceuticals USD 1.63B 127.5M Sep/2025